资产 更改
Akzo Nobel EUR 16.13B 647M 2026-06
Alcon AG USD 31.62B 64M 2026-03
Almirall EUR 2.37B 29.97M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BASF EUR 83.87B 2.1B 2026-06
Bayer EUR 107.29B 659M 2026-06
Beiersdorf EUR 12.76B 166M 2025-12
Covestro EUR 13.47B 245M 2025-12
Demant DKK 39.07B 6.43B 2025-12
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Geberit CHF 3.86B 252.6M 2025-12
Genmab DKK 12.52B 139M 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GN Store Nord DKK 28.56B 671M 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Johnson Matthey GBP 5.97B 142M 2026-06
Merck EUR 52.69B 383M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Philips EUR 26.7B 565M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sika AG CHF 15.15B 245M 2025-12
Smith & Nephew USD 11.01B 321M 2026-06
Solvay EUR 6.08B 122M 2026-06
UCB EUR 18.16B 971M 2025-12